{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-028330","form_type":"8-K","ticker":"ADVB","cik":"0001941029","company_name":"Advanced Biomed Inc.","filed_at":"2026-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.833742+00:00","generated_at":"2026-05-15T11:58:00.634739+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Advanced Biomed regains Nasdaq compliance after reverse stock split; stock remains listed","bullets":["Received Panel decision on March 12, 2026 confirming compliance with Minimum Bid Price Rule.","Reverse stock split completed Feb 20, 2026 brought closing bid price to $1.00+.","Company will remain listed on Nasdaq subject to one-year Panel monitor under Rule 5815(d)(4)(A).","Previously appealed delisting determination on Jan 21, 2026; hearing held Feb 17, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-028330","json":"https://secwatch.observer/filing/0001213900-26-028330.json","markdown":"https://secwatch.observer/filing/0001213900-26-028330.md","text":"https://secwatch.observer/filing/0001213900-26-028330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1941029/000121390026028330/0001213900-26-028330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1941029/000121390026028330/ea0281688-8k_advanced.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:58:00.634739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}